Apr. 6, 2010 Researchers have discovered a fifth genetic mutation associated with typical motor neuron disease, or amyotrophic lateral sclerosis, that has a similar pathological effect to certain genetic mutations revealed in earlier studies. Ultimately, the researchers hope that understanding what is causing motor neuron disease (MND), also known as Lou Gehrig's disease, will lead to new avenues for treatment.
MND is a progressive neurodegenerative disease that attacks the upper and lower motor neurons. Degeneration of the motor neurons leads to weakness and wasting of muscles, causing increasing loss of mobility in the limbs, and difficulties with speech, swallowing and breathing.
The new research, published in the journal Proceedings of the National Academy of Sciences and led by researchers from Imperial College London, provides strong further genetic evidence that the disease is caused by proteins clumping together in motor neurons, which are the cells that help to control the movement of muscles.
The effect of proteins clumping together in this way, known as protein aggregation, is toxic and it ultimately kills motor neurons. Protein aggregation is believed to be involved in other neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Previous studies have found a similar association between genetic mutations linked to protein aggregation and MND.
The newly discovered mutation, known as R199W-DAO, has been found in a family with a genetic history of MND. R199W promotes toxic protein aggregation inside motor neurons. It also interferes with levels of D-serine, which modulates the transfer of information between neurons. D-serine accumulates in the spinal cord in people with the sporadic form of MND, suggesting that this plays a role in the disease.
Professor Jackie de Belleroche, the lead author of the study from the Department of Neurosciences and Mental Health at Imperial College London, said: "Motor Neuron Disease is a fatal condition for which there is currently no cure. Our finding is one valuable piece in the puzzle to show what's happening with the disease. Unfortunately we're a long way from finding a cure for MND, but it's only through understanding how MND works that we'll be able to find new ways to treat it."
The researchers discovered the new mutation after looking at 20 members of a family with the genetically inherited form of MND, known as familial MND. Children of a parent with familial MND have a one in two risk of inheriting the disease.
In the study, all of the family members with motor neuron disease had the R199W mutation, whereas none of the individuals with parents unaffected by the disease carried it.
Dr Brian Dickie, director of research development at the Motor Neurone Disease Association, said: "Identifying definitive causes of motor neuron disease (MND), no matter how rare, is of vital importance. It will allow scientists to compare one form of MND with another, to more rapidly identify the common biochemical events that dictate whether a motor neuron lives or dies, no matter what the original cause of the disease is. It serves as a springboard for much greater understanding of MND -- and it is through this understanding that effective treatments will be developed."
The researchers did not find the R199W mutation when they looked at a larger population of unrelated people. They looked at the genetic makeup of 1,002 individuals, 780 of whom had no history of motor neuron disease, 23 who had sporadic MND, and 199 who had familial MND, and found no incidences of the mutation.
However, even though this mutation is rare, they believe that its presence in only those family members with MND means it provides valuable further clues about what is causing the disease.
This research was carried out by scientists from Imperial College London, King's College London and the Institute of Psychiatry, London. It was funded by the Motor Neurone Disease Association, the Smith's Charity, the American ALS Association, the Haywood Foundation, the Garfield Weston Foundation, and Land Securities Group.
Other social bookmarking and sharing tools:
- J. Mitchell, P. Paul, H. J. Chen, A. Morris, M. Payling, M. Falchi, J. Habgood, S. Panoutsou, S. Winkler, V. Tisato, A. Hajitou, B. Smith, C. Vance, C. Shaw, N. D. Mazarakis, J. de Belleroche. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proceedings of the National Academy of Sciences, 2010; DOI: 10.1073/pnas.0914128107
Note: If no author is given, the source is cited instead.